Cardiovascular Organoids With Adjustable Endothelial Composition via SOX17‐Engineered hPSCs
Biotechnology and Bioengineering · 2026
DOI: 10.1002/bit.70275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von Po-Yu Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA. Hauptthemen laut MEDLINE: Organoids, SOXF Transcription Factors, Pluripotent Stem Cells, Myocytes, Cardiac. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSF, NIBIB NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Organoids are considered a novel modeling platform for studying human biology and advancing health research. With the ability to demonstrate complex 3D structure and multicellular interactions, organoids have advanced studies in all major organs as a reliable model. In this study, we generated an advanced cardiovascular organoid by using a genome‐edited human pluripotent stem cell line with inducible SOX17 expression, enabling controlled endothelial specification, adjustable cell‐type composition, and human heart‐like morphology. Our organoids recapitulated the cardiotoxic phenotypes of FDA‐approved chemotherapeutic doxorubicin, manifesting as decreased cell viability and diminished contractile activity. Cryoinjury‐induced myocardial infarction in our organoids led to reduced beating, viability, and α‐actinin expression, along with increased fibroblast formation, which were mitigated by Captopril. Lastly, isoproterenol treatment increased peak Ca 2+ transient amplitude and shortened APD 50 in our organoids, consistent with previously reported β‐adrenergic responses. In summary, we established a protocol for generating in vitro 3D cardiovascular organoids with controllable cellular composition and heart‐like structures, providing a robust and easy‐to‐produce platform for future studies of human heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA.
- Purdue Institute for Cancer Research, West Lafayette, Indiana, USA.
- Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, USA.
- Department of Biomedical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.
- The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, Pennsylvania, USA.
- Department of Biology, The Pennsylvania State University, University Park, Pennsylvania, USA.
Förderung
- NSF
- NIBIB NIH HHS
- NCI NIH HHS
- NIH HHS
- NIDDK NIH HHS
- NIH
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Liang, P. Y., Jin, G., Petrucci, N. R., Lian, X. L., & Bao, X. (2026). Cardiovascular Organoids With Adjustable Endothelial Composition via SOX17‐Engineered hPSCs. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70275
Vancouver
Liang PY, Jin G, Petrucci NR, Lian XL, Bao X. Cardiovascular Organoids With Adjustable Endothelial Composition via SOX17‐Engineered hPSCs. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70275
BibTeX
@article{Liang2026,
author = {Liang, Po-Yu and Jin, Gyuhyung and Petrucci, Nathan R and Lian, Xiaojun Lance and Bao, Xiaoping},
title = {Cardiovascular Organoids With Adjustable Endothelial Composition via SOX17‐Engineered hPSCs},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70275}
}
EUVIMED